EKO / TSX Venture Exchange
MONTREAL, March 20 /CNW Telbec/ - Noveko International Inc. ("Noveko" or
the "Company") is pleased to announce that the TSX Venture Exchange (the
"Exchange") approved the reclassification of the Company from Tier 2 Issuer to
Tier 1 Issuer. Tier 1 is the Exchange's premier tier and is reserved for the
Exchange's most advanced issuers with the most significant financial
Pursuant to its Policy 2.5, this graduation will, among others, change
the release schedule for its escrow securities to a Tier 1 Issuer release
schedule. Consequently, all the 3,150,000 Class A Shares and the
630,000 warrants not yet released from escrow will be released within 10 days
of the Exchange Bulletin confirming the Issuer's listing as a Tier 1 Issuer.
Noveko International Inc. currently has four subsidiaries: S.A.S. ECM,
Noveko Inc., Laboratoire SyMa Inc. ("SyMa") and Bolduc Leroux Inc. ("BLI").
ECM specializes in the design and marketing of portable real-time ultrasound
scanners for use in veterinary and human medicine. Noveko Inc. develops the
Company's biomedical and environmental business, specifically its patented
antimicrobial filtration technology and derivative products (Noveko(TM)
antimicrobial face masks and air filters). SyMa specializes in the manufacture
of sanitizers, more specifically the antimicrobial products (for hands, feet
and surfaces) sold under the Azuro(TM) trademark. For its part, BLI
specializes in the custom processing and distribution of steel products based
on client specifications and designs. It has also developed and markets a line
of downdraft particle extraction tables for various markets. Operating since
September 2002, the Company was listed on the TSX Venture Exchange on
February 3, 2004.
The information set forth in this press release includes certain
forward-looking statements. Such statements are based on assumptions exposed
to major risks and uncertainties. Although Noveko deems the expectations
reflected in these forward-looking statements to be reasonable, the Company
cannot provide any guarantee as to the materialization of the expectations
reflected in these forward-looking statements.
The TSX Venture Exchange has not reviewed and does not accept
responsibility for the adequacy or accuracy of this release.
For further information:
For further information: André Leroux, Chairman of the Board and Chief
Executive Officer; Alain Bolduc, President and Chief Operating Officer, Noveko
International Inc., (514) 344-3030, http://www.noveko.com